Tech Company Financing Transactions

Arbor Biotechnologies Funding Round

Arch Venture Partners, TCGX and Abrdn participated in a $73.9 million Series C funding round for Arbor Biotechnologies. This VC investment round was announced on 3/18/2025.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

20 Acorn Park Dr. 500
Cambridge, MA 02140
USA

Phone

Undisclosed

Website

www.arbor.bio

Email Address

[email protected]

Overview

We envision a world in which all patients with serious genetic diseases can be treated with curative genetic medicines. We start with the patient in mind, working to understand the underlying genetic pathology of disease.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Devyn Smith

        

Chief Operating Officer

Pam Stetkiewicz

        

Chief Scientific Officer

John Murphy

        

Chief Technical Officer

David Cheng

        

Co-Founder

David Scott

        

Vice President

Kelly Morgan

        

VP - Bus. Development

Kathryn McCabe

        

Browse more venture capital transactions:

Prev: 3/18/2025: Evera venture capital transaction
Next: 3/18/2025: AICA venture capital transaction

Share this article

About Database of VC Transactions

We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are derived from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary